品牌现货直购
供应商:我要出现这里




查看所有供应商和价格请点击:

1080622-86-1生产厂家

1080622-86-1价格

1080622-86-1

1080622-86-1结构式
1080622-86-1结构式

化源商城直购

中文名 1-(6,7-二甲氧基-4-喹唑啉基)-3-(2-吡啶基)-1H-1,2,4-三唑-5-胺
英文名 2-(6,7-dimethoxyquinazolin-4-yl)-5-pyridin-2-yl-1,2,4-triazol-3-amine
英文别名 1H-1,2,4-Triazol-5-amine, 1-(6,7-dimethoxy-4-quinazolinyl)-3-(2-pyridinyl)-
S2245_Selleck
HMS3265A20
1-(6,7-Dimethoxy-4-quinazolinyl)-3-(2-pyridinyl)-1H-1,2,4-triazol-5-amine
cc-85
HMS3265A19
HMS3265B19
CP466722
CP-466722
描述 CP-466722 是一种可逆的 ATM 抑制剂,IC50 值为 4.1 μM,但对 PI3K,PIKK 家族蛋白没有作用。
相关类别
靶点

ATM:4.1 μM (IC50)

体外研究 CP-466722(CP466722,6-10μM)抑制IR诱导的ATM激酶活性,并且抑制可以快速且完全逆转。 CP466722(6,10μM)抑制小鼠细胞中p53诱导和ATM依赖性磷酸化,但CP466722不能抑制Chk1的ATR活性和ATR依赖性磷酸化。 CP466722(6μM)破坏细胞中依赖ATM的细胞周期检查点[1]。 CP466722(1μM)完全抑制MCF7细胞中的ATM依赖性磷酸化。 CP466722(10μM)可降低MCF7细胞中的pKAP1磷酸化,IC50为0.41μM。 CP466722(10μM)抑制pATM和pKAP1信号[2]。 CP-466722(CP466722,5-50μM)比MCF-7癌细胞更强烈地抑制SKBr-3癌细胞的增殖。 CP466722(10μM)在处理48小时后也略微增加了G1期MCF-7和SKBr-3细胞的比例[3]。
激酶实验 为了筛选ATM激酶活性的小分子抑制剂,进行体外激酶测定,并开发ELISA测定法,其测量ATM下游靶标p53的磷酸化状态。纯化重组GST-p53(1-101)和全长Flag标记的ATM和ATR用于ELISA和体外激酶测定。简言之,将Nunc 96孔Maxisorp板用PBS中的2μg纯化的重组GST-p53(1-101)包被过夜(4℃)。所有后续孵育均在室温下进行。将板洗涤(0.05%v / v-Tween / PBS),然后加入纯化的重组全长ATM激酶(30-60ng),最终体积为80μL反应缓冲液(20mM HEPES,50mM NaCl2,在化合物存在或不存在下,10mM MgCl 2,10mM MnCl 2,1mM DTT和1μMATP)。将包括CP-466722(10μM)的化合物一式两份加入板中,并孵育激酶测定法(90分钟)。洗涤平板(0.05%v / v-吐温/ PBS),封闭(1小时,1%w / v-BSA / PBS)并在抗磷酸化(Ser15)-p53抗体(1:1000 / PBS)之前冲洗。加入板中并孵育(1小时)。为了减少非特异性结合板,在用HRP缀合的山羊抗兔IgG二抗(1:5000 / PBS)温育(1小时)之前洗涤(0.05%v / v-Tween / PBS)。用TMB底物试剂检测与磷酸化GST-p53(1-101)蛋白连接的二抗。开发平板(15-30分钟)并在确定吸光度(λ450nm)之前停止反应(1M H 2 SO 4终浓度)。在ELISA测定中抑制ATM激酶活性的化合物的特征在于使用体外激酶测定法抑制ATM / ATR激酶。使用抗磷酸化(Ser15)-p53抗体的Western印迹用作ATM / ATR抑制的读数[1]。
细胞实验 将细胞一式三份(40,000个细胞/板)铺板,根据需要孵育,然后将培养基和胰蛋白酶消化的细胞组合并测定活力:Vi-CELL TM XR细胞活力分析仪[1]。
参考文献

[1]. Rainey MD, et al. Transient inhibition of ATM kinase is sufficient to enhance cellular sensitivity to ionizing radiation. Cancer Res. 2008 Sep 15;68(18):7466-74.

[2]. Guo K, et al. Development of a cell-based, high-throughput screening assay for ATM kinase inhibitors. J Biomol Screen. 2014 Apr;19(4):538-46.

[3]. Węsierska-Gądek J, et al. Interactions Between Ataxia Telangiectasia Mutated Kinase Inhibition, Poly(ADP-ribose) Polymerase-1 Inhibition and BRCA1 Status in Breast Cancer Cells. J Cancer Prev. 2014 Jun;19(2):125-36.

密度 1.5±0.1 g/cm3
沸点 642.3±65.0 °C at 760 mmHg
分子式 C17H15N7O2
分子量 349.347
闪点 342.2±34.3 °C
精确质量 349.128723
PSA 114.59000
LogP 0.83
外观性状 white to beige
蒸汽压 0.0±1.9 mmHg at 25°C
折射率 1.737
储存条件 2-8°C
水溶解性 DMSO: soluble0.5mg/mL, clear (warmed)

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name: CP466722
REACH No.: A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No.: 1080622-86-1
Relevant identified uses of the substance or mixture and uses advised against
Identified uses: Laboratory chemicals, Manufacture of substances



SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn HarmfulR22
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal wordWarning
Hazard statement(s)
H302Harmful if swallowed.
Precautionary statement(s)none
Supplemental Hazardnone
Statements
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.

SECTION 3: Composition/information on ingredients
Substances
Synonyms: 1-(6,7-Dimethoxy-4-quinazolinyl)-3-(2-pyridinyl)-1H-1,2,4-Triazol-5-amine
Formula: C17H15N7O2
Molecular weight: 349,35 g/mol
CAS-No.: 1080622-86-1
Hazardous ingredients according to Regulation (EC) No 1272/2008
ComponentClassificationConcentration
CP466722
CAS-No.1080622-86-1Acute Tox. 4; H30250 - 100 %
Hazardous ingredients according to Directive 1999/45/EC
ComponentClassificationConcentration
CP466722
CAS-No.1080622-86-1Xn, R22<= 100 %
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
No data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
No data available
Advice for firefighters
Wear self-contained breathing apparatus for firefighting if necessary.
Further information
No data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature 2 - 8 °C
Storage class (TRGS 510): Non Combustible Solids
Specific end use(s)
Apart from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Do not let product enter drains.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) AppearanceForm: solid
b) OdourNo data available
c) Odour ThresholdNo data available
d) pHNo data available
e) Melting point/freezingNo data available
point
f) Initial boiling point and No data available
boiling range
g) Flash pointNo data available
h) Evaporation rateNo data available
i) Flammability (solid, gas) No data available
j) Upper/lowerNo data available
flammability or
explosive limits
k) Vapour pressureNo data available
l) Vapour densityNo data available
m) Relative densityNo data available
n) Water solubilityNo data available
o) Partition coefficient: n- log Pow: 2,339
octanol/water
p) Auto-ignitionNo data available
temperature
q) DecompositionNo data available
temperature
r) ViscosityNo data available
s) Explosive propertiesNo data available
t) Oxidizing propertiesNo data available
Other safety information
No data available

SECTION 10: Stability and reactivity
Reactivity
No data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
No data available
Conditions to avoid
No data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - No data available
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
No data available
Skin corrosion/irritation
No data available
Serious eye damage/eye irritation
No data available
Respiratory or skin sensitisation
No data available
Germ cell mutagenicity
No data available
Carcinogenicity
IARC:No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
No data available
Specific target organ toxicity - single exposure
No data available
Specific target organ toxicity - repeated exposure
No data available
Aspiration hazard
No data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
No data available
Persistence and degradability
No data available
Bioaccumulative potential
No data available
Mobility in soil
No data available
Results of PBT and vPvB assessment
This substance/mixture contains no components considered to be either persistent, bioaccumulative and
toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
Other adverse effects
No data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: -IMDG: -IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA:Not dangerous goods
Transport hazard class(es)
ADR/RID: -IMDG: -IATA: -
Packaging group
ADR/RID: -IMDG: -IATA: -
Environmental hazards
ADR/RID: noIMDG Marine pollutant: noIATA: no
Special precautions for user
No data available

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
No data available
Chemical Safety Assessment
For this product a chemical safety assessment was not carried out

SECTION 16: Other information
Full text of H-Statements referred to under sections 2 and 3.
Acute Tox.Acute toxicity
H302Harmful if swallowed.
Full text of R-phrases referred to under sections 2 and 3
Xn Harmful
R22 Harmful if swallowed.
Further information
Copyright 2014 Co. LLC. License granted to make unlimited paper copies for internal use
only.
The above information is believed to be correct but does not purport to be all inclusive and shall be
used only as a guide. The information in this document is based on the present state of our knowledge
and is applicable to the product with regard to appropriate safety precautions. It does not represent any
guarantee of the properties of the product. Corporation and its Affiliates shall not be held
liable for any damage resulting from handling or from contact with the above product. See
and/or the reverse side of invoice or packing slip for additional terms and conditions of sale.
符号 GHS07
GHS07
信号词 Warning
危害声明 H302
危害码 (欧洲) Xn
风险声明 (欧洲) 22
危险品运输编码 NONH for all modes of transport